BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//DEMENTIA RESEARCHER - ECPv6.14.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:DEMENTIA RESEARCHER
X-ORIGINAL-URL:https://www.dementiaresearcher.nihr.ac.uk
X-WR-CALDESC:Events for DEMENTIA RESEARCHER
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261116
DTEND;VALUE=DATE:20261120
DTSTAMP:20260927T070559
CREATED:20260108T120508Z
LAST-MODIFIED:20260817T154000Z
UID:10002036-1794787200-1795132799@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Clinical Trials on Alzheimer’s Disease Conference
DESCRIPTION:The Clinical Trials on Alzheimer’s Disease (CTAD) Conference\, established in 2008\, has become a cornerstone event in Alzheimer’s disease (AD) clinical research. Designed by and for AD researchers\, CTAD’s mission is to create a platform that prioritizes substantive\, clinical research-focused dialogue and collaboration. By fostering an intimate and collegial environment\, CTAD has gained a reputation for facilitating impactful international collaborations and advancing the global AD research agenda. \nThe upcoming 18th annual Clinical Trials on Alzheimer’s Disease Conference (CTAD26) to be held in Boston (USA) on November 16-19\, 2026. CTAD26 will build on the momentum of previous years\, reflecting the rapid advancements in Alzheimer’s disease diagnostics and therapeutics that make this field one of the most dynamic in medical research today. \nCTAD26 also features thought-provoking roundtables and symposia that explore the latest advancements in AD research. Renowned clinicians and leaders from academia\, research centers\, patient coalitions\, and pharmaceutical companies engage in dynamic discussions on diverse topics\, from disease-modifying agents to gene therapy\, vaccines\, and multimodal interventions. \nFind out More
URL:https://www.dementiaresearcher.nihr.ac.uk/event/clinical-trials-on-alzheimers-disease-conference/
LOCATION:Boston Marriott Copley Place\, 110 Huntington Ave\, Boston\, MA\, MA 02116\, United States
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2025/07/CTAD-Logo-2025.png
GEO:42.3463738;-71.0781901
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=Boston Marriott Copley Place 110 Huntington Ave Boston MA MA 02116 United States;X-APPLE-RADIUS=500;X-TITLE=110 Huntington Ave:geo:-71.0781901,42.3463738
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20261116T133000
DTEND;TZID=Europe/London:20261118T164500
DTSTAMP:20260927T070559
CREATED:20260924T185204Z
LAST-MODIFIED:20260924T185204Z
UID:10002401-1794835800-1795020300@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Qualitative AI Course: Generative AI in NVivo and MAXQDA
DESCRIPTION:How do you bring generative AI into qualitative analysis without letting the tools drive the method? This hands-on online course from NCRM shows you how to integrate AI capabilities into established qualitative software\, and what that means for your practice. \nThis is Module 3 of NCRM’s Navigating Qualitative AI course\, led by Dr Christina Silver. Through demonstrations\, guided exercises and discussion\, you’ll work with sample data to explore a series of analytic tasks\, and consider the methodological implications of using AI with different types of data and at different stages of qualitative analysis. The focus is on existing qualitative software\, using NVivo and MAXQDA as the core examples. \nSession 1: Principles of integrating AI tools into qualitative analysis (16 November\, 13:30–16:45) \n\nOverview of what established qualitative software can do\, with and without AI\nMaking sure your analytic methods drive the use of AI tools\nHands-on exercises using NVivo\n\nSession 2: Exploring MAXQDA’s AI tools for qualitative analysis (18 November\, 13:30–16:45) \n\nOverview of MAXQDA’s tools\nHands-on exercises bringing AI into a qualitative analysis process\, using literature\, transcripts and open-ended survey responses\n\nBy the end of the course participants will: \n\nUnderstand where AI tools can be used at different stages of the qualitative analysis workflow\nUnderstand the methodological consequences of using AI tools\, both the potential and the risks\nIdentify ways of using AI tools that keep the approach human-centred\n\nThe course is aimed at students and researchers interested in qualitative analysis\, in any sector or discipline. It is pitched at intermediate level. \nYou must have completed Module 1 before taking this module. Module 1\, Mindsets for considering the use of AI for Qualitative Research\, runs on 30 September and 1 October and again on 2 and 4 November. \nTHIS COURSE IS TAUGHT OVER TWO AFTERNOONS AND EQUATES TO ONE TEACHING DAY FOR PAYMENT PURPOSES. \nCost: \nThe fee per teaching day is: \n• £60 per day for students registered at any university\n• £150 per day for staff at academic institutions\, Research Councils researchers\, public sector staff\, staff at registered charity organisations and recognised research institutions\n• £350 per day for all other participants \nIn the event of cancellation by the delegate a full refund of the course fee is available up to two weeks prior to the course. No refunds are available after this date. \nFind out More
URL:https://www.dementiaresearcher.nihr.ac.uk/event/navigating-qualitative-ai-integrating-generative-ai-into-qualitative-analysis-online/
LOCATION:Online
CATEGORIES:Training
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2021/10/NCRM.png
END:VEVENT
END:VCALENDAR